NAD
|
Basic information |
| Metabolite name | NAD |
 | HMDB0000902 |
 |
C00003 |
 |
5893 |
| Synonyms | beta-nicotinamide adenine dinucleotide; |
| No. of studies | 10 |
|
Basic information |
| Metabolite name | NAD |
| HMDB0000902 |
|
C00003 |
|
5893 |
| Synonyms | beta-nicotinamide adenine dinucleotide; |
| No. of studies | 10 |
|
Relationship between NAD and depression (count: 10) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M033 | Type3 | paroxetine group vs. control group | Hippocampus | DBA/2OlaHsd mouse | Down |
| Study M1091 | Type1 | CMS vulnerable group vs. control group | Ventral hippocampus | Wistar rat | Down |
| Study M1092 | Type1 | CMS group vs. control group | Ventral hippocampus | Wistar rat | Down |
| Study M1092 | Type3 | venlafaxine group vs. control group | Ventral hippocampus | Wistar rat | Down |
| Study M1107 | Type1 | CRS group vs. control group | Colon | C57/6 J mouse | Up |
| Study M1107 | Type2 | CRS + FMT of healthy controls group vs. CRS group | Prefrontal cortex | C57/6 J mouse | Up |
| Study M1108 | Type1 | CRS group vs. control group | Colon | C57/6 J mouse | Up |
| Study M1108 | Type1 | CRS group vs. control group | Prefrontal cortex | C57/6 J mouse | Up |
| Study M1108 | Type2 | CRS + Roseburia Intestinalis. group vs. CRS group | Colon | C57/6 J mouse | Down |
| Study M613 | Type1 | CSDS susceptible group vs. control group | Medial prefrontal cortex | C57BL/6 J mouse | Up |
| Study M651 | Type1 | LPS group vs. control group | Brain | C57BL/6 mouse | Down |
| Study M651 | Type2 | LPS + fish oil group vs. LPS group | Brain | C57BL/6 mouse | Up |
| Study M664 | Type1 | CSDS group vs. control group | Prefrontal cortex | C57BL/6 J mouse | Up |
| Study M664 | Type2 | CSDS + Dl-3-n-butylphthalide group vs. CSDS group | Hippocampus | C57BL/6 J mouse | Down |
| Study M669 | Type1 | corticosterone group vs. control group | Liver | C57BL/6J mouse | Down |
| Study M928 | Type1 | CUMS group vs. control group | Faece | C57BL/6 mouse | Down |